Reflections on Medicine and Life by Dr. S.P. Kalantri
Clinical stories and reflections on evidence-based medicine, research, and patient care.
Dr Priya Mendiratta wrote a post on my poem on Favipiravir and Covid. Thank you Dr SP Kalantri for still guiding us to always practice ethically, not abandon logical thinking and scientific approach . Dr Kalantri’s thoughts on Favipiravir, a new oral drug launched in India yesterday by Glenmark to fight Covid19 infection. He is … Read more
On 18 June 2020, Dr. C. S. Pramesh, the Director of the Tata Memorial Hospital texted me a message and then called me asking if I would be willing to do a talk on Covid and research during Pandemic. A day after. Although I had little time to prepare, I didn’t blink an eyelid to … Read more
WHO had resumed trials of the drug hydroxychloroquine as a part of the Solidarity Trial to find a cure for the novel coronavirus, COVID-19. The trial had been stopped because a study published in The Lancet said the drug wasn’t as effective as touted. This study is now under the scanner after investigation by the … Read more
How are COVID-19 vaccines being developed? Several drugmakers have announced that they are moving to Phase 2 of COVID-19 vaccine clinical trials; the Oxford vaccine by Serum Institute of India backed by Adar Poonawala has started Phase 3 clinical trials. What do these phases mean? Should we think that we are close to a getting … Read more
No other drug, at least in the early phase of Covid pandemic, evoked as much interest, publicity, blind and demand as Hydroxychloroquine did. It took a couple of well -designed randomized controlled trials to indicate that the drug does not work, and is associated with serious adverse events when used to prevent or treat Covid. … Read more